PER was Antisense Therapeutics ASX ANP had a name and ticker change earlier in the year. Like ATH they are progressing well with trials and have orphan drug designation for their target. I have a bit more invested in ATH as I like the possible wider applications and think it has more upside when you consider the potential to treat Parkinson’s disorders and Alzheimers. Needless to say that both ATH and PER have the potential to change lives with what they are doing and it is good to be able to support both companies.
PER was Antisense Therapeutics ASX ANP had a name and ticker...
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
-0.001(16.7%) |
Mkt cap ! $26.22M | |||
| Open | High | Low | Value | Volume |
| 0.5¢ | 0.5¢ | 0.5¢ | $130.5K | 26.11M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 106 | 98813145 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.5¢ | 13634538 | 6 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| ATH (ASX) Chart |